Asia Pacific Digital Dose Inhaler Market Size, Share & Industry Trends Analysis Report By Product (Metered Dose Inhaler (MDI), and Dry Powder Inhaler (DPI)), By Type, By Indication (COPD, Asthma, and Others), By Country and Growth Forecast, 2023

List of Tables

The Asia Pacific Digital Dose Inhaler Market would witness market growth of 20.7% CAGR during the forecast period (2023-2030).

Using digital dose inhalers can alleviate the difficulties that patients and medical professionals face when treating respiratory disorders. Due to their interconnected digital capabilities, smart inhalers and mobile applications work together to monitor medication administration schedules and subsequent doses. Digital dose inhalers can deliver track adherence and dosage reminders, accurately record the date, time, and location of every dose administered, and offer Bluetooth access to readily shareable data.

Patients may medicate themselves while using a digital dose inhaler by swiftly inhaling an aerosolized medicine into their lungs in line with a predetermined dose. The market is seeing a rapid expansion of inhalation therapy devices, including meters that inhalers integrated with an e-dose counter, internet-connected and compact inhalers, and others.

Asia is the largest and most populous continent in the globe. Asia's most prevalent chronic disease is asthma. In Asia, the prevalence of pediatric asthma has steadily increased over the past five decades [5]. The activity of asthma research in Asian countries has multiplied over the past decade, a reflection of the disease's growing significance. COPD is a significant health concern and a leading cause of chronic morbidity and mortality. The prevalence of COPD continues to rise in Asian nations. These increases are primarily attributable to the tobacco pandemic and interior and outdoor air pollution in Asian nations. In terms of the total number of fatalities and the burden of disease, determined in years of life lost and years spent living with disability, the burden of COPD in Asia is presently greater than in developed Western countries. This rising incidence of COPD and asthma in the nation is anticipated to contribute to expanding the regional market.

The China market dominated the Asia Pacific Digital Dose Inhaler Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $3,222.4 million by 2030. The Japan market is registering a CAGR of 19.8% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 21.2% during (2023 - 2030).

Based on Product, the market is segmented into Metered Dose Inhaler (MDI), and Dry Powder Inhaler (DPI). Based on Type, the market is segmented into Branded Medication, and Generic Medication. Based on Indication, the market is segmented into COPD, Asthma, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Sensirion AG, Teva Pharmaceuticals Industries Ltd., OPKO Health, Inc., Propeller Health (ResMed, Inc.), Novartis AG, AstraZeneca PLC, Glenmark Pharmaceuticals Limited, Beximco Pharmaceuticals Ltd., GlaxoSmithKline PLC and Mundipharma Deutschland GmbH & Co. KG.

Scope of the Study

Market Segments covered in the Report:

By Product

Metered Dose Inhaler (MDI)
Dry Powder Inhaler (DPI)

By Type

Branded Medication
Generic Medication

By Indication

COPD
Asthma
Others

By Country

China
Japan
India
South Korea
Singapore
Malaysia
Rest of Asia Pacific

Companies Profiled

Sensirion AG
Teva Pharmaceuticals Industries Ltd.
OPKO Health, Inc.
Propeller Health (ResMed, Inc.)
Novartis AG
AstraZeneca PLC
Glenmark Pharmaceuticals Limited
Beximco Pharmaceuticals Ltd.
GlaxoSmithKline PLC
Mundipharma Deutschland GmbH & Co. KG

Unique Offerings from KBV Research

Exhaustive coverage
Highest number of market tables and figures
Subscription based model available
Guaranteed best price
Assured post sales research support with 10% customization free

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 Asia Pacific Digital Dose Inhaler Market, by Product
- 1.4.2 Asia Pacific Digital Dose Inhaler Market, by Type
- 1.4.3 Asia Pacific Digital Dose Inhaler Market, by Indication
- 1.4.4 Asia Pacific Digital Dose Inhaler Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
3.3 Porter's Five Force Analysis

Chapter 4. Strategies Deployed in Digital Dose Inhaler Market

Chapter 5. Asia Pacific Digital Dose Inhaler Market by Product

5.1 Asia Pacific Metered Dose Inhaler (MDI) Market by Country
5.2 Asia Pacific Dry Powder Inhaler (DPI) Market by Country

Chapter 6. Asia Pacific Digital Dose Inhaler Market by Type

6.1 Asia Pacific Branded Medication Market by Country
6.2 Asia Pacific Generic Medication Market by Country

Chapter 7. Asia Pacific Digital Dose Inhaler Market by Indication

7.1 Asia Pacific COPD Market by Country
7.2 Asia Pacific Asthma Market by Country
7.3 Asia Pacific Others Market by Country

Chapter 8. Asia Pacific Digital Dose Inhaler Market by Country

8.1 China Digital Dose Inhaler Market
- 8.1.1 China Digital Dose Inhaler Market by Product
- 8.1.2 China Digital Dose Inhaler Market by Type
- 8.1.3 China Digital Dose Inhaler Market by Indication
8.2 Japan Digital Dose Inhaler Market
- 8.2.1 Japan Digital Dose Inhaler Market by Product
- 8.2.2 Japan Digital Dose Inhaler Market by Type
- 8.2.3 Japan Digital Dose Inhaler Market by Indication
8.3 India Digital Dose Inhaler Market
- 8.3.1 India Digital Dose Inhaler Market by Product
- 8.3.2 India Digital Dose Inhaler Market by Type
- 8.3.3 India Digital Dose Inhaler Market by Indication
8.4 South Korea Digital Dose Inhaler Market
- 8.4.1 South Korea Digital Dose Inhaler Market by Product
- 8.4.2 South Korea Digital Dose Inhaler Market by Type
- 8.4.3 South Korea Digital Dose Inhaler Market by Indication
8.5 Singapore Digital Dose Inhaler Market
- 8.5.1 Singapore Digital Dose Inhaler Market by Product
- 8.5.2 Singapore Digital Dose Inhaler Market by Type
- 8.5.3 Singapore Digital Dose Inhaler Market by Indication
8.6 Malaysia Digital Dose Inhaler Market
- 8.6.1 Malaysia Digital Dose Inhaler Market by Product
- 8.6.2 Malaysia Digital Dose Inhaler Market by Type
- 8.6.3 Malaysia Digital Dose Inhaler Market by Indication
8.7 Rest of Asia Pacific Digital Dose Inhaler Market
- 8.7.1 Rest of Asia Pacific Digital Dose Inhaler Market by Product
- 8.7.2 Rest of Asia Pacific Digital Dose Inhaler Market by Type
- 8.7.3 Rest of Asia Pacific Digital Dose Inhaler Market by Indication

Chapter 9. Company Profiles

9.1 Sensirion AG
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Regional Analysis
- 9.1.4 Research & Development Expenses
- 9.1.5 SWOT Analysis
9.2 Teva Pharmaceutical Industries Ltd.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Regional Analysis
- 9.2.4 Research & Development Expenses
- 9.2.5 Recent strategies and developments:
  - 9.2.5.1 Partnerships, Collaborations, and Agreements:
  - 9.2.5.2 Product Launches and Product Expansions:
- 9.2.6 SWOT Analysis
9.3 OPKO Health, Inc.
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 SWOT Analysis
9.4 Propeller Health (ResMed, Inc.)
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expenses
- 9.4.5 Recent strategies and developments:
  - 9.4.5.1 Partnerships, Collaborations, and Agreements:
- 9.4.6 SWOT Analysis
9.5 Novartis AG
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 Recent strategies and developments:
  - 9.5.5.1 Approvals and Trials:
- 9.5.6 SWOT Analysis
9.6 AstraZeneca PLC
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 Recent strategies and developments:
  - 9.6.5.1 Approvals and Trials:
- 9.6.6 SWOT Analysis
9.7 Glenmark Pharmaceuticals Limited
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 Recent strategies and developments:
  - 9.7.5.1 Product Launches and Product Expansions:
- 9.7.6 SWOT Analysis
9.8 Beximco Pharmaceuticals Ltd.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Research & Development Expenses
- 9.8.4 SWOT Analysis
9.9 GlaxoSmithKline PLC (GSK)
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 Recent strategies and developments:
  - 9.9.5.1 Product Launches and Product Expansions:
- 9.9.6 SWOT Analysis
9.10. Mundipharma Deutschland GmbH & Co. KG
- 9.10.1 Company Overview
- 9.10.2 SWOT Analysis

LIST OF TABLES

TABLE 1 Asia Pacific Digital Dose Inhaler Market, 2019 - 2022, USD Million
TABLE 2 Asia Pacific Digital Dose Inhaler Market, 2023 - 2030, USD Million
TABLE 3 Asia Pacific Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
TABLE 4 Asia Pacific Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
TABLE 5 Asia Pacific Metered Dose Inhaler (MDI) Market by Country, 2019 - 2022, USD Million
TABLE 6 Asia Pacific Metered Dose Inhaler (MDI) Market by Country, 2023 - 2030, USD Million
TABLE 7 Asia Pacific Dry Powder Inhaler (DPI) Market by Country, 2019 - 2022, USD Million
TABLE 8 Asia Pacific Dry Powder Inhaler (DPI) Market by Country, 2023 - 2030, USD Million
TABLE 9 Asia Pacific Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
TABLE 10 Asia Pacific Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
TABLE 11 Asia Pacific Branded Medication Market by Country, 2019 - 2022, USD Million
TABLE 12 Asia Pacific Branded Medication Market by Country, 2023 - 2030, USD Million
TABLE 13 Asia Pacific Generic Medication Market by Country, 2019 - 2022, USD Million
TABLE 14 Asia Pacific Generic Medication Market by Country, 2023 - 2030, USD Million
TABLE 15 Asia Pacific Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
TABLE 16 Asia Pacific Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
TABLE 17 Asia Pacific COPD Market by Country, 2019 - 2022, USD Million
TABLE 18 Asia Pacific COPD Market by Country, 2023 - 2030, USD Million
TABLE 19 Asia Pacific Asthma Market by Country, 2019 - 2022, USD Million
TABLE 20 Asia Pacific Asthma Market by Country, 2023 - 2030, USD Million
TABLE 21 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
TABLE 22 Asia Pacific Others Market by Country, 2023 - 2030, USD Million
TABLE 23 Asia Pacific Digital Dose Inhaler Market by Country, 2019 - 2022, USD Million
TABLE 24 Asia Pacific Digital Dose Inhaler Market by Country, 2023 - 2030, USD Million
TABLE 25 China Digital Dose Inhaler Market, 2019 - 2022, USD Million
TABLE 26 China Digital Dose Inhaler Market, 2023 - 2030, USD Million
TABLE 27 China Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
TABLE 28 China Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
TABLE 29 China Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
TABLE 30 China Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
TABLE 31 China Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
TABLE 32 China Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
TABLE 33 Japan Digital Dose Inhaler Market, 2019 - 2022, USD Million
TABLE 34 Japan Digital Dose Inhaler Market, 2023 - 2030, USD Million
TABLE 35 Japan Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
TABLE 36 Japan Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
TABLE 37 Japan Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
TABLE 38 Japan Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
TABLE 39 Japan Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
TABLE 40 Japan Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
TABLE 41 India Digital Dose Inhaler Market, 2019 - 2022, USD Million
TABLE 42 India Digital Dose Inhaler Market, 2023 - 2030, USD Million
TABLE 43 India Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
TABLE 44 India Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
TABLE 45 India Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
TABLE 46 India Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
TABLE 47 India Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
TABLE 48 India Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
TABLE 49 South Korea Digital Dose Inhaler Market, 2019 - 2022, USD Million
TABLE 50 South Korea Digital Dose Inhaler Market, 2023 - 2030, USD Million
TABLE 51 South Korea Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
TABLE 52 South Korea Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
TABLE 53 South Korea Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
TABLE 54 South Korea Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
TABLE 55 South Korea Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
TABLE 56 South Korea Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
TABLE 57 Singapore Digital Dose Inhaler Market, 2019 - 2022, USD Million
TABLE 58 Singapore Digital Dose Inhaler Market, 2023 - 2030, USD Million
TABLE 59 Singapore Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
TABLE 60 Singapore Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
TABLE 61 Singapore Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
TABLE 62 Singapore Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
TABLE 63 Singapore Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
TABLE 64 Singapore Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
TABLE 65 Malaysia Digital Dose Inhaler Market, 2019 - 2022, USD Million
TABLE 66 Malaysia Digital Dose Inhaler Market, 2023 - 2030, USD Million
TABLE 67 Malaysia Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
TABLE 68 Malaysia Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
TABLE 69 Malaysia Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
TABLE 70 Malaysia Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
TABLE 71 Malaysia Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
TABLE 72 Malaysia Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
TABLE 73 Rest of Asia Pacific Digital Dose Inhaler Market, 2019 - 2022, USD Million
TABLE 74 Rest of Asia Pacific Digital Dose Inhaler Market, 2023 - 2030, USD Million
TABLE 75 Rest of Asia Pacific Digital Dose Inhaler Market by Product, 2019 - 2022, USD Million
TABLE 76 Rest of Asia Pacific Digital Dose Inhaler Market by Product, 2023 - 2030, USD Million
TABLE 77 Rest of Asia Pacific Digital Dose Inhaler Market by Type, 2019 - 2022, USD Million
TABLE 78 Rest of Asia Pacific Digital Dose Inhaler Market by Type, 2023 - 2030, USD Million
TABLE 79 Rest of Asia Pacific Digital Dose Inhaler Market by Indication, 2019 - 2022, USD Million
TABLE 80 Rest of Asia Pacific Digital Dose Inhaler Market by Indication, 2023 - 2030, USD Million
TABLE 81 Key Information - Sensirion AG
TABLE 82 Key Information - Teva Pharmaceuticals Industries Ltd.
TABLE 83 Key Information - OPKO Health, Inc.
TABLE 84 Key Information - Propeller Health
TABLE 85 Key Information - Novartis AG
TABLE 86 KEY INFORMATION - AstraZeneca PLC
TABLE 87 Key Information - Glenmark Pharmaceuticals Limited
TABLE 88 Key Information - Beximco Pharmaceuticals Ltd.
TABLE 89 Key Information - GlaxoSmithKline PLC
TABLE 90 Key Information - Mundipharma Deutschland GmbH & Co. KG

List of Figures

FIG 1 Methodology for the research
FIG 2 Asia Pacific Digital Dose Inhaler Market, 2019 - 2030, USD Million
FIG 3 Key Impacting Factors digital dose inhaler market
FIG 4 Porter's Five Force Analysis: Digital Dose Inhaler Market
FIG 5 Asia Pacific Digital Dose Inhaler Market share by Product, 2022
FIG 6 Asia Pacific Digital Dose Inhaler Market share by Product, 2030
FIG 7 Asia Pacific Digital Dose Inhaler Market by Product, 2019 - 2030, USD Million
FIG 8 Asia Pacific Digital Dose Inhaler Market share by Type, 2022
FIG 9 Asia Pacific Digital Dose Inhaler Market share by Type, 2030
FIG 10 Asia Pacific Digital Dose Inhaler Market by Type, 2019 - 2030, USD Million
FIG 11 Asia Pacific Digital Dose Inhaler Market share by Indication, 2022
FIG 12 Asia Pacific Digital Dose Inhaler Market share by Indication, 2030
FIG 13 Asia Pacific Digital Dose Inhaler Market by Indication, 2019 - 2030, USD Million
FIG 14 Asia Pacific Digital Dose Inhaler Market share by Country, 2022
FIG 15 Asia Pacific Digital Dose Inhaler Market share by Country, 2030
FIG 16 Asia Pacific Digital Dose Inhaler Market by Country, 2019 - 2030, USD Million
FIG 17 SWOT Analysis: SENSIRION AG
FIG 18 Recent strategies and developments: Teva Pharmaceuticals Industries Ltd.
FIG 19 SWOT Analysis: Teva Pharmaceuticals Industries Ltd.
FIG 20 SWOT Analysis: OPKO Health, Inc.
FIG 21 SWOT Analysis: Propeller Health
FIG 22 SWOT Analysis: Novartis AG
FIG 23 SWOT Analysis: AstraZeneca PLC
FIG 24 SWOT Analysis: Glenmark Pharmaceuticals Ltd.
FIG 25 SWOT Analysis: Beximco Pharmaceuticals Ltd.
FIG 26 SWOT Analysis: GlaxoSmithKline PLC
FIG 27 SWOT Analysis: Mundipharma Deutschland GmbH & Co. KG

Asia Pacific Digital Dose Inhaler Market Size, Share & Industry Trends Analysis Report By Product (Metered Dose Inhaler (MDI), and Dry Powder Inhaler (DPI)), By Type, By Indication (COPD, Asthma, and Others), By Country and Growth Forecast, 2023 - 2030

Description

Table of Contents